Acadia Nuplazid patent ruling removes ‘key overhang,’ says BMO Capital

finance.yahoo.com/news/acadia-nuplazid-patent-ruling-removes-173623052.html

In This Article:
BMO Capital analyst Evan Seigerman notes that a U.S. district court issued a ruling in favor of Acadia Pharmaceuticals (ACAD) in their Nuplazid patent infringement lawsuit with Aurobindo, confirming today that Aurobindo infringed on claims 4 and 5 of Acadia’s 11,452,721…

This story appeared on finance.yahoo.com, 2025-05-17 17:36:23.
The Entire Business World on a Single Page. Free to Use →